Moran Kevin Patrick 4
4 · Vanda Pharmaceuticals Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2023-06-15$6.29/sh−16,000$100,710→ 122,926 total
Holdings
- 635(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.23 to $6.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.